Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

223
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
223
Decreased pulse rate01:14

Decreased pulse rate

546
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
546
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

7
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
7
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

13
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
13
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

13
Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
13

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

HIF1α Attenuates Doxorubicin-Induced Cardiotoxicity by Activating TEX264-Associated ER-phagy.

Journal of the American Heart Association·2026
Same author

Associations between extreme temperatures and hospitalizations among Chinese cancer patients with atrial fibrillation: a case-crossover study.

Cardio-oncology (London, England)·2026
Same author

Breast tumour-secreted ADAM10 mediates atrial fibrogenesis and fibrillation.

European heart journal·2026
Same author

GSTP1 inhibits angiotensin II-induced atrial fibrillation by regulating ferroptosis.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same author

Patterns of Anticoagulation Use and All-Cause of Mortality in Cancer Patients with Atrial Fibrillation.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2023
Same author

Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice.

Pharmaceuticals (Basel, Switzerland)·2023
Same journal

Cohort profile: Sheyang Mini Birth Cohort Study (SMBCS).

BMJ open·2026
Same journal

Quebec lung, liver and heart transplant recipients' perspectives on self-narratives and their experiences in creative writing workshops during the transplantation journey: a qualitative study.

BMJ open·2026
Same journal

Impact of climatic variables on postoperative outcomes in various surgical disciplines: a systematic review.

BMJ open·2026
Same journal

ADHD and cardiometabolic risk profile in adults with type 2 diabetes: a longitudinal register-based study.

BMJ open·2026
Same journal

Understanding the impact of the follow-up period on the association between excess body weight, and cardiovascular events and mortality: a prospective cohort study of the UK Biobank.

BMJ open·2026
Same journal

Temporal associations between incident physical health problems/sensory impairments and challenging behaviours in people with intellectual disabilities: a population-based longitudinal cohort study of primary care in England.

BMJ open·2026
查看所有相关文章

相关实验视频

Updated: Jul 11, 2025

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
09:20

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Published on: July 5, 2021

3.1K

节功能障碍和中风风险:系统性审查和元分析.

Haoyu Dong1, Hao Chen1, Tesfaldet Habtemariam Hidru1

  • 1Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.

BMJ open
|November 17, 2023
PubMed
概括
此摘要是机器生成的。

鼻节功能障碍 (SND) 的患者面临着类似的中风风险,无论他们是否有心房动 (AF). 这凸显了对所有SND患者中风预防策略的需要.

科学领域:

  • 心脏病学 心脏病学
  • 神经学 神经学
关键词:
这是一种抗凝血药物.这是一个元分析.有关风险因素的风险因素.鼻节的功能障碍 鼻节的功能障碍一次性中风中风中风中风中风

更多相关视频

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K
Location, Dissection, and Analysis of the Murine Stellate Ganglion
07:50

Location, Dissection, and Analysis of the Murine Stellate Ganglion

Published on: December 22, 2020

10.4K

相关实验视频

Last Updated: Jul 11, 2025

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
09:20

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Published on: July 5, 2021

3.1K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K
Location, Dissection, and Analysis of the Murine Stellate Ganglion
07:50

Location, Dissection, and Analysis of the Murine Stellate Ganglion

Published on: December 22, 2020

10.4K
  • 临床研究 临床研究
  • 背景情况:

    • 与心律不整相关的中风风险,特别是心房动 (AF),是已知的.
    • 然而,在患有鼻节功能障碍 (SND),有或没有同时存在的AF的患者中,特定的中风风险仍然不清楚.
    • 这项研究通过比较这些患者群体中风风险来弥补这一差距.

    结论:

    • 患有SND的患者表现出类似的中风风险,无论心房是否存在.
    • 这些发现强调了考虑所有SND患者的中风预防措施的重要性.
    • 需要进一步的研究来评估干预措施的有效性,如在SND患者中预防中风的抗凝固疗法.